Crossmark

Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms

Crossref DOI link: https://doi.org/10.1186/s12885-016-2072-0

Published Online: 2016-01-25

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ito, Kimihiro

Mitsunaga, Makoto

Arihiro, Seiji

Saruta, Masayuki

Matsuoka, Mika

Kobayashi, Hisataka

Tajiri, Hisao
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (26710010)

Uehara Memorial Foundation

Kato Memorial Bioscience Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Takeda Science Foundation

Kowa Life Science Foundation

Nakayama Cancer Research Institute

The Jikei University Research Fund
License Information

Text and Data Mining valid from 2016-01-25

Version of Record valid from 2016-01-25
More Information

Article History

Received: 28 July 2015

Accepted: 19 January 2016

First Online: 25 January 2016

Document is current

Any future updates will be listed below